Citrus fruits and their flavonoids in inflammatory bowel disease: an overview

Inflammatory bowel disease (IBD), with its major manifestations being Crohn's disease and ulcerative colitis, belongs to the gastrointestinal inflammatory disorders, whose main therapeutic approach is represented by synthetic anti-inflammatory drugs. However, they are often accompanied by many...

Full description

Saved in:
Bibliographic Details
Published inNatural product research Vol. 34; no. 1; pp. 122 - 136
Main Authors Musumeci, Laura, Maugeri, Alessandro, Cirmi, Santa, Lombardo, Giovanni Enrico, Russo, Caterina, Gangemi, Sebastiano, Calapai, Gioacchino, Navarra, Michele
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 02.01.2020
Taylor & Francis Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Inflammatory bowel disease (IBD), with its major manifestations being Crohn's disease and ulcerative colitis, belongs to the gastrointestinal inflammatory disorders, whose main therapeutic approach is represented by synthetic anti-inflammatory drugs. However, they are often accompanied by many side effects that shifted the interest of the scientific community towards natural products. In this context, several studies asserted the anti-IBD effects of Citrus fruits and their flavonoids, thus the aim of the present review is to provide robust evidence favouring their role in the prevention and treatment of IBD. Key mechanisms relate to their anti-inflammatory and antioxidant properties, as well as their ability to modulate gut microbiota. All the findings collected in this review, lay the foundations for further studies in human with the aim of evaluating the concrete applicability as a novel preventive and therapeutic approach of Citrus fruits and their flavonoids.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1478-6419
1478-6427
DOI:10.1080/14786419.2019.1601196